JULIE GOLDSTEIN: Open Payments
NPI 1275176042 · WINTER GARDEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,796 in 72 payments from 13 companies in 2025. Trend: 2023 $697 · 2024 $795 · 2025 $1,796
Food & beverage: $1,729Education: $67
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $492 |
| Janssen Biotech, Inc. | 19 | $478 |
| Regeneron Healthcare Solutions, Inc. | 11 | $381 |
| GENZYME CORPORATION | 3 | $90 |
| LEO Pharma Inc. | 4 | $84 |
| Organon LLC | 3 | $72 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Galderma Laboratories, L.P. | 1 | $32 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $30 |
| STRATA Skin Sciences, Inc. | 2 | $25 |
Products named: TREMFYA, DUPIXENT, RINVOQ, SKYRIZI, COSENTYX, ANZUPGO, VTAMA, ADBRY.
Industry payments across FL — which companies pay providers there.
